Details for Patent: 9,192,608

« Back to Dashboard

Which drugs does patent 9,192,608 protect, and when does it expire?

Patent 9,192,608 protects MORPHINE SULFATE and is included in one NDA.

This patent has ten patent family members in seven countries.

Summary for Patent: 9,192,608

Title:	Morphine formulations
Abstract:	Provided herein, generally, are pharmaceutical formulations, e.g., injectable pharmaceutical formulations with improved stability, comprising morphine sulfate or a hydrate thereof, and methods of producing and using the same. Also provided herein are kits comprising the formulations, e.g., injectable morphine formulations.
Inventor(s):	Alain Cuine, Didier Hoarau, Pauline Romain
Assignee:	Fresenius Kabi Deutschland GmbH
Application Number:	US14/715,277
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 9,192,608

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Fresenius Kabi Usa	MORPHINE SULFATE	morphine sulfate	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	204223-001	Oct 30, 2013		RX	Yes	Yes						MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA
Fresenius Kabi Usa	MORPHINE SULFATE	morphine sulfate	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	204223-001	Oct 30, 2013		RX	Yes	Yes						TREATMENT OF PAIN
Fresenius Kabi Usa	MORPHINE SULFATE	morphine sulfate	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	204223-002	Oct 30, 2013		RX	Yes	Yes						MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA

International Family Members for US Patent 9,192,608

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014230834
Brazil	112015021586
Canada	2902343